RxDoctor Payments Data

Eric Swenson, DPM

Foot & Ankle Surgery · Thibodaux, LANPI 1407351828

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,429 of the $12,121 with a category attached, or 61.3%. Stryker accounts for 68.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $3,980 and has fallen 75.3% since, to $983 in 2025.

$12,121in general payments, 2019–2025

Across 167 payments — averaging $72.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$8K
  • ALON Medical Technology$1K
  • Medline Industries LP$856
  • Medical Device Business Services, Inc.$677
  • SPR Therapeutics, Inc$205
  • Medartis Inc.$197
  • plus $657 from 10 others

What the payments were for

  • Travel & lodging$3,44728%
  • Food & beverage$7,42961%
  • Education$1,20010%
  • Gifts$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,121 in reported general payments places this provider in the 85th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$145,398
Medicare patients
430
Services billed
2,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium50$302
Cephalexin62$266
Celecoxib21$248
Methylprednisolone30$229
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$217
Clotrimazole13$214
Doxycycline Hyclate11$177
Oxycodone Hcl26$139
Clindamycin Hcl18$113
Hydroxyzine Pamoate17$63

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →